parkinson's Flashcards
what is parkinson’s disease
progressive neurodegenerative disorder
starts slowly and progresses gradually
brain cells are lost due to abnormal protein aggregation (a-synuclein), mitochondrial dysfunction
dopaminergic cells in the brain (substantia nigra), other monoaminergic cells in brainstem
2nd most common neurodegenerative disorder after alzheimers disease
parkinson’s dsease is primarily caused by
loss of dopaminergic cells in the brain (substantia nigra), other monoaminergic cells in the brainstem also lost
cardinal features of parkinson’s disease
bradykinesia tremor rest posture and action regidity postural reflex impairment
pathogenesis of parkinson’s disease
toxic processes - oxidative stress, mitochodnrial dysfunction, toxins
gene mutations - a-synuclein, parkin
susceptibility - decreased expression of UPS components (age related), decreased UPS activity
leads to ubiquitin dependant proteasomal proteolysis system failure
staging of PD
stage 1 - dorsal motor nucleus of the vagal nerve, anterior olfactory structures
stage 2 - lower raphe nuclei, locus coeruleus
stage 3 - substantia nigra; anygdala; nucleus basilis of Maynert (clinical diagnosis)
stage 4 temporal mesocortex
stage 5 - temporral neocortex; sensory association and premotor areas
stage 6 - neocortex; primary sensory and motor areas
diagnosis of PD
mainly clinical - hisstory and examination
tests to rulle out other causes
- MRI scan of the brain
- metabolic/genetic testing in children/young adults
special tests if necesary
- DOPA PET, dopamine transporter scans
- MIBG heart scan
DAT scan
dopaminergic transporter scan
secondary parkinson’s
drugs, toxins, stroke, infections, head injury
parkinson-like tremors
essential tremork dystonic tremor
tremor due to drugs
symptoms of PD
motor (asymmetrical) - tremor, rigidity, bradykinesia - posture, gait, balance - micrographia, hypophonia, facial expression non-motor - olfactory, RBD - blood pressure, bladder, bowel, swallowing - fatigue, pain, sleep - attention, concentration, memory - mood, psychosis
prognosis of PD
most people with PD can live relatively normal lives in the first 5-10 years, many for over 15-20 years
life expectancy is reduced by up to 10%
disability in later stags
what responds best to drugs
rigidity and bradykinesia
tremor and gait
what does not respond optimally to drugs
balance, gait freezing
classes of drugs for parkinsons
L-Dopa
dopamine agonists
MAO-B inhibitors
amantadine, anticholinergics
L DOPA metabolism
converted to dopamine in the brain
prevented from turning into dopamine in the blood
MAO and COMT break down dopamine